Skip to content

Use of a New Method for the Microbiological Diagnosis of Severe Corneal Infection

Use of a New Rapid Multiplex PCR System for the Microbiological Diagnosis of Severe Infectious Keratitis: Impact on Therapeutic Management (ABCORFILM Study)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05888987
Acronym
ABCORFILM
Enrollment
46
Registered
2023-06-05
Start date
2023-07-07
Completion date
2027-08-07
Last updated
2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Corneal Infection, Infectious Keratitis, Microbial Keratitis

Keywords

Severe infectious keratitis, Infectious keratitis, Microbial keratitis, Corneal infection, FilmArray, Multiplex PCR system

Brief summary

Microbial keratitis is a severe and often blindness-inducing pathology which represents today the first reason for long-term hospitalization (more than 5 days) in ophthalmology. Its diagnosis is clinical and leads to an immediate hospitalization in the presence of serious criteria (Mackie classification). The entire process of microbiological diagnosis requires several days before etiological confirmation and therefore delays the initiation of targeted therapy. Recently, new PCR systems allowing the detection of 18 to 27 pathogens in 75 minutes have been developed. Their use could thus be transposed to ophthalmology by adapting the microbiological diagnostic technique to samples currently taken by swabbing the cornea. The investigators will compare their diagnosis performance versus conventional methods on patients who suffered for a microbial keratitis with severity criteria.

Detailed description

46 patients enrolled for severe infectious keratitis will be recruited in the department of Ophthalmology, Robert Debré Hospital, Reims, France. The study will be composed by 2 groups. The first, also called before group will contain 23 patients who were anteriorly hospitalized for a severe infectious keratitis in our hospital unit. They received standard microbiological diagnosis methods: Direct microscopic examination with Gram stain, bacterial and fungal cultures, viral and amoebic polymerase chain reaction \[PCR\]). The second, also called after group will enroll patients who suffer for a severe infectious keratitis (prospective group). Each patient will benefit a complete ophthalmologic examination, corneal scrapping and swabbing for standard microbiological diagnosis methods along with another corneal swabbing sample for the use of two different FilmArray® PCR systems identified as ME for Meningitis-Encephalitis and BCID for Blood Culture Identification. The investigators hypothesize that the use of rapid multiplex PCR tests for the microbiological diagnosis of severe corneal infections could in the future prove to be more efficient than the current diagnostic strategy, on the one hand, by shortening the time to identify the pathogen and therefore to implement a targeted treatment, and on the other hand, by systematically searching for a large number of pathogens well beyond those targeted today. In addition, the benefits of this technique applied to ophthalmology could improve the long-term visual prognosis, reduce the length of hospitalization and therefore the diagnostic and management costs of these patients.

Interventions

BIOLOGICALPCR multiplex by FilmArray

PCR multiplex by FilmArray system on corneal swabbing sample

Sponsors

CHU de Reims
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Over 18 years old * With social security affiliation * Willing to participate this study * Hospitalized in our department for severe infectious keratitis Non-inclusion criteria: * Any prior (48 hours) or concomitant treatment with local or systemic antibiotherapy at time of corneal scrapping and swabbing * Patient not covered by the French Health Insurance * Unable to give informed consent

Design outcomes

Primary

MeasureTime frame
Time to modification of the first line antimicrobial treatment towards a treatment targeting the detected pathogen.At 2 weeks

Secondary

MeasureTime frame
Duration of hospitalizationAt 1 month
Best corrected visual acuityAt 12 months
Modification of the initial antimicrobial treatment after detection of the etiological agentAt 1 month
Descriptive analysis of pathogens responsible for severe infectious keratitis in Champagne-ArdenneAt 1 month
• Costs of diagnostic methods (conventional and FilmArray) and management (cost of the average length of stay in ophthalmology at the Reims University Hospital for severe infectious keratitis)At 1 month

Countries

France

Contacts

Primary ContactAlexandre DENOYER
adenoyer@chu-reims.fr03 26 78 78 88
Backup ContactThomas Ferreira de Moura
tferreira-de-moura@chu-reims.fr03 26 78 78 88

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026